BMDMs treated with αIFNAR1 antibody exhibited no difference in the expression of the M1 markers such as Nos2 (nitric oxide synthase 2) and Tnf as compared to control group at 24 h post-infection (Fig. 5A). The gene discussed is NOS2; the disease is infection.